About
Technology
Issues
FAQ
Links
Official Page
Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301/KEYNOTE-252): a phase 3, randomised, double-blind study
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.